BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4971469)

  • 1. A pilot study of AL-449 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):533-6. PubMed ID: 4971469
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
    Edwards JG; Simpson GM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
    [No Abstract]   [Full Text] [Related]  

  • 3. A pilot study of AL-1021 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
    [No Abstract]   [Full Text] [Related]  

  • 4. A pilot study of CI-601 in chronic schizophrenics.
    Sugerman AA; Herrmann J; O'Hara M
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):529-32. PubMed ID: 4971468
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot study of AHR-1900 in chronc schizophrenic patients.
    Sugerman AA; Herrmann J; O'Hara M
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):234-6. PubMed ID: 4989873
    [No Abstract]   [Full Text] [Related]  

  • 6. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 7. A double-blind comparison of AL-1021 and chlorpromazine in hospitalized schizophrenics.
    Gendron JL; Zimmermann RL; Schiele BC
    Curr Ther Res Clin Exp; 1973 Jun; 15(6):333-6. PubMed ID: 4197258
    [No Abstract]   [Full Text] [Related]  

  • 8. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
    Lehmann HE; Ban TA; Lee H
    Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021
    [No Abstract]   [Full Text] [Related]  

  • 9. Lenperone: a controlled evaluation in chronic schizophrenic patients.
    Mielke DH; Gallant DM; Kessler C; Roniger JJ
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):636-40. PubMed ID: 812640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of triperidol with perphenazine in schizophrenic psychoses. Effect on the photomyoclonic threshold].
    Náhunek K; Hádlík J; Rodová A; Misurec J; Vanýsek J
    Act Nerv Super (Praha); 1970 Jan; 12(1):56-7. PubMed ID: 4907390
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled comparative study of methylperidol and perphenazine in schizoprenic psychoses].
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1970 Jan; 12(1):57-8. PubMed ID: 4907391
    [No Abstract]   [Full Text] [Related]  

  • 13. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot study on the use of AL-1021 in the treatment of acute schizophrenics.
    Gendron JL; Schiele BC
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):169-73. PubMed ID: 4998288
    [No Abstract]   [Full Text] [Related]  

  • 15. A new butyrophenone derivative. AL-1021.
    Gallant DM; Bishop MP; Guerrero-Figueroa R; O'Meallie L
    Curr Ther Res Clin Exp; 1969 Jul; 11(7):456-9. PubMed ID: 4979994
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of trifluperidol in chronic schizophrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4916807
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of the schizophrenic patient in a community psychiatric practice.
    Tobin JM
    Dis Nerv Syst; 1968 May; 29(5):Suppl:27-34. PubMed ID: 4876987
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of trifluperidol in chronic schizaphrenia.
    Clark ML; Huber WK; Kyriakopoulos AA; Ray TS; Colmore JP; Ramsey HR
    Psychopharmacologia; 1968; 12(3):193-203. PubMed ID: 4917285
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
    Sathanathan GL; Angrist BM; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):844-7. PubMed ID: 4217252
    [No Abstract]   [Full Text] [Related]  

  • 20. Two pilot studies of AHR-1680 in chronic schizophrenic patients.
    Sugerman AA; Herrmann J; O'Hara M; Simpson GM; Angus JW; Deutsch L
    J Clin Pharmacol J New Drugs; 1969; 9(3):183-6. PubMed ID: 4892454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.